BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 9441097)

  • 1. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
    Diagbouga S; Fumoux F; Ledru E; Sanou PT; Barro D; Marchal G
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):317-23. PubMed ID: 9559403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis infection in pregnant and nonpregnant women infected with HIV in the Women and Infants Transmission Study.
    Mofenson LM; Rodriguez EM; Hershow R; Fox HE; Landesman S; Tuomala R; Diaz C; Daniels E; Brambilla D
    Arch Intern Med; 1995 May; 155(10):1066-72. PubMed ID: 7748050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
    Klein RS; Gourevitch MN; Teeter R; Schoenbaum EE
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):707-11. PubMed ID: 11495260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.
    Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):804-9. PubMed ID: 15115092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
    Stephan C; Wolf T; Goetsch U; Bellinger O; Nisius G; Oremek G; Rakus Z; Gottschalk R; Stark S; Brodt HR; Staszewski S
    AIDS; 2008 Nov; 22(18):2471-9. PubMed ID: 19005270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of positive tuberculin reactions in women with or at risk for HIV-1 infection. HER Study Group. HIV Epidemiology Research.
    Klein RS; Smith D; Sobel J; Flanigan T; Margolick JB
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):688-92. PubMed ID: 10907773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantoux reaction in patients with HIV-related pulmonary tuberculosis in Maiduguri, Nigeria.
    Yusuph H; Garbati MA; Gashau W
    Afr J Med Med Sci; 2005 Jun; 34(2):125-8. PubMed ID: 16749335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with positive tuberculin skin test results among HIV-infected persons in Orel Oblast, Russia.
    Vitek E; Gusseinova N; Laricheva N; Vasiliev S; Molotilov V; Sofronova R; Kazionny B; Cegielski P; Nguyen ML; Nelson L; Agerton T; Wells C
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):829-35. PubMed ID: 19555531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-stage tuberculin skin testing in an HIV-infected population: a preliminary report.
    Goldstein S; Perlman DC; Salomon N
    Mt Sinai J Med; 1994 Sep; 61(4):337-40. PubMed ID: 7969227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values.
    Cobelens FG; Egwaga SM; van Ginkel T; Muwinge H; Matee MI; Borgdorff MW
    Clin Infect Dis; 2006 Sep; 43(5):634-9. PubMed ID: 16886159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H;
    Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
    Sudre P; Rieder H; Bassetti S; Hirschel BJ; Ledergerber B; Malvy D
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2007-12. PubMed ID: 8984608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-step tuberculin skin testing in HIV-infected persons in Uganda.
    Hecker MT; Johnson JL; Whalen CC; Nyole S; Mugerwa RD; Ellner JJ
    Am J Respir Crit Care Med; 1997 Jan; 155(1):81-6. PubMed ID: 9001293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients.
    Amicosante M; Richeldi L; Monno L; Cuboni A; Tartoni PL; Angarano G; Orefici G; Saltini C
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):435-40. PubMed ID: 9441098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand.
    Do AN; Limpakarnjarat K; Uthaivoravit W; Zuber PL; Korattana S; Binkin N; Mastro TD; Jarvis WR
    Int J Tuberc Lung Dis; 1999 May; 3(5):377-81. PubMed ID: 10331725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ; Aldamiz-Etxebarria M; Agud JM; Arévalo JM; Almaraz MJ; Ayensa C
    Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.